-
Pfizer vaccine news sounds great — but it’s still data by press release
Pfizer made waves Monday with its announcement that its COVID-19 vaccine, developed with partner BioNTech, is “strongly effective,” with a…
-
While still an expensive therapy, doctors see promise in harnessing a patient’s immune system to fight cancer
If you write anything about cancer treatment, it’s nearly impossible to avoid writing about immunotherapy. But reporting on immunotherapy can…
-
New resource can help you assess hazards and risks and odds ratios
Over the years, I’ve presented on reporting medical research findings. Some of the most common questions I get are about…
-
Use analogies to provide perspective for tricky numbers ― such as COVID-19 fatality rates
It’s no secret that humans are horrible at comprehending and estimating risk, especially when it comes to abstract numbers. It’s…
-
Know the nuances of vaccine efficacy when covering COVID-19 vaccine trials
I’ve written in previous posts about what to look for in COVID-19 vaccine trials and red flags to monitor. The…
-
Freshen your skills with online course on reading medical studies
When it comes to feeling competent about understanding, interpreting and reporting on medical studies, one under-appreciated fact is that this…
-
Tracker a one-stop-shop for monitoring COVID-19 vaccine development
It’s been a dizzying task for reporters trying to keep up with the development of COVID-19 vaccines. There are the…
-
Watch out for these red flags in COVID-19 vaccine trials
In a previous blog post, I discussed what reporters look for when they dig into the data from the various…
-
What to look for in COVID-19 vaccine trials
As various COVID-19 vaccine candidates make their way through clinical trials — see this nice update on where things stand…
-
How reporting on people’s intent to get a COVID-19 vaccine can harm public health
A recent Pew Research poll found that the proportion of Americans who said they would get a COVID-19 vaccine when…